Screening for Co-Crystals with a Solubility-based Approach with Crystal16

Technobis Crystallization Systems B.V.

Discover a systematic approach for screening co-crystals

Within the pharma industry, active ingredients are commonly formulated as solid dosages. However, the properties of the solid form of the actives are not always ideal. Therefore, crystal engineering is often employed to improve properties. Co-crystals are a form of crystal engineering that is gaining an increased level of interest within pharma. Co-crystals are a multicomponent complex, similar to salts, solvates and hydrates, where a second molecule is incorporated into the crystal lattice. However, unlike other complexes, the second molecule must be neutral and not a solvent.

This application note discusses how to set up a systematic approach to screening co-crystals that allows you to collect solubility data fast and reliably.

Content overview:

  • What are co-crystals and why are they interesting?
  • The improved physicochemical properties by co-crystallization
  • Salt vs co-crystal differences
  • The systematic approach to screening co-crystals
  • How to construct phase diagrams

Download white paper now

Screening for Co-Crystals with a Solubility-based Approach with Crystal16

Discover a systematic approach for screening co-crystals

Technobis Crystallization Systems B.V.

You may also be interested in these white papers

How is High-Throughput Multi-Parameter Flow Cytometry used in Biopharma?

Tracking Polymorph and Crystal Morphology using Non-Invasive In Situ Analysis at Small Scale

Solubility: Importance, Measurements and Applications

Solubility and crystallization of coloured compounds captured with high resolution cameras

From experimentation to modelling: understanding the effect of solvent composition on solubility

Calculate Nucleation Rate from Induction Time Measurements. Theory and Application